TGF-β1 is a central mediator of DKD pathogenesis being a main regulator of ECM protein expression in patients with diabetes, probably as a result of hyperglycemic and disturbed oxidative environment [7–10]. The gene discussed is TGFB1; the disease is diabetes mellitus.